SlideShare a Scribd company logo
ERROR TRAPPING AND
ERROR AVOIDANCE
IN
HISTOPATHOLOGY
Error rates in diagnostic
histopathology
 A typical histopathologist becomes aware of having
made a serious diagnostic error about once a year
 Overall diagnostic error – 3 to 4%
 Clinically significant error – 1 to 2%
 “Zero error rate” – cannot be achieved even with use of
automated re-screening devices
Classification of diagnostic errors
Category 1 A diagnostic error which would have a
definite influence on clinical management
and possible outcome
Category 2 A diagnostic misinterpretation or oversight
which has the potential to affect clinical
management or outcome
Category 3 A minor discrepancy of disease
categorization likely to be of little clinical
significance
What sort of errors are
made?
 Oversight errors
 Misinterpretation errors
 Errors are rarely due to incompetence, lack of
knowledge or inability to do the work
 Other factors – heavy workload
 Areas where pathologists tend to make more mistakes –
lymphoma, melanoma, prostate needle biopsies.
 Physical impairment of visual function, colour blindness
 There is no evidence that pathologists with inability to
distinguish subtle colour hues perform less well than
others
Individual professional
performance
Pathologists should be
 Up-to-date with their specialist knowledge
 Right skills and attitude to manage services
 Communicate effectively
 Audit their performance
 Re – validation or re-licensing process
Good pathology practice
Pathologists should
 Assure the quality of clinical advice given and
associated record keeping
 Ensure the quality and timeliness of pathology reports
and clinical advice
 Undertake routine review (audit) of a sample of clinical
cases / reports in selected areas
 Show that individual diagnostic patterns compare
favourably with their peers
 Offer appropriate treatment, management or diagnostic
decision making
 Describe the distribution of their workload and case-mix
Professional behaviour and
working relationships
All pathologists must
 Be available and willing to communicate and discuss
clinical and professional issues with colleagues
 Know their own diagnostic limitations as demonstrated
by their referral patterns
 Participate in clinicopathological discussions or
multidisciplinary team meetings
 Work well in a team
 Ensure that there are no tensions relating to private
practice, coroner’s work or outside commitments
Identifying poor performance
 Identifying underperforming pathologists
 Errors should not be judged in isolation but in the
context of pathologist’s overall performance
 The performance of doctors should be assessed using
Cambridge model approach, which applies a range of
methods and indicators that take into account both
individual competence and day-to-day work context
Factors leading to increased risk of
errors and poor performance in
histopathology
 Conditions of work, staffing and workload
 Locum working in unfamiliar surroundings
 Potential constraints on performance in the laboratory
 Low volume work or case-mix and where the pathologist
may be working outside his or her expertise
 Isolated or single-handed practice
Clinical audit
 Reliable and systematized audit practice
 Audit is used to monitor diagnostic and service
standards and identify and prevent errors
 Audit and peer review are useful in reducing
inaccuracies in reports
Specialist reporting
 Specialist reporting reduces the number of errors made
Quality improvement systems
Type of review Process
Intradepartmental consultation Review of selected cases by colleagues
Intra- operative consultation
(frozen section)
Review of frozen section diagnosis in the light of
final paraffin wax section diagnosis
Random case review
Re-reporting of a random sample from all cases
submitted
Clinical indicator audit
Cases selected on a clinical basis checked over
a given period to ensure consistency in
diagnosis and reporting
Multidisciplinary Team Meeting
Comparison of presented diagnosis against
reported diagnoses
Inter- institutional review
Comparison of local diagnoses with outside
review diagnoses
Reporting patterns
Comparison of pattern of reporting among group
of pathologists
Quality improvement systems
Type of review Process
Workload profile Audit of busy and quiet periods
Turnaround times Audit of time taken to produce reports
Specimen adequacy
Monitoring identification and processing of
specimens
Lost specimens Monitoring number of lost specimens
Histology quality control
Assessment of times of delivery of slides and
quality of staining
Other methods to detect
errors
 Consistency in reporting
 Patterns of error -analysis of diagnostic pattern( use of
inappropriate or inconsistent terminology)
 Case referral
 Multidisciplinary team meetings
 Use of guidelines and datasets
 External quality assurance
 Risk management
 Adverse incident reporting
 Hindsight bias
Conclusions
 The detection of errors and error avoidance depends upon
individuals practising to the highest standards by ensuring
they are up-to-date
 Pathologists should be willing to monitor their own
performance, know their limitations and communicate with
peers
 Pathologists should engage in the process of developing
standardized approaches to macroscopic description,
specimen sampling, special stains and histological reporting
 The laboratories in which pathologists work should have
systematized method of audit, quality improvement and IT
systems to analyze the data and to identify poor performance
at an early stage
Thank you…
To make no mistakes is not in the power of
man; but from their errors and mistakes
the wise and good learn wisdom for the
future.

More Related Content

What's hot

Immunohistochemistry of Thyroid Gland tumor
Immunohistochemistry of Thyroid Gland tumorImmunohistochemistry of Thyroid Gland tumor
Immunohistochemistry of Thyroid Gland tumor
home education
 
The Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary CytologyThe Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary Cytology
Rawa Muhsin
 
Giant cell lesions of bone
Giant cell lesions of boneGiant cell lesions of bone
Giant cell lesions of bone
Shreya D Prabhu
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
BPS GMC (W) KHANPUR KALAN SONEPAT
 
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminarImmunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Pannaga Kumar
 
Dr shashi bansal approch to bone marrow examination
Dr shashi bansal  approch to bone marrow examinationDr shashi bansal  approch to bone marrow examination
Dr shashi bansal approch to bone marrow examination
Shashi Bansal
 
Genetic origins of human cancer - recent advances
Genetic origins of human cancer  - recent advancesGenetic origins of human cancer  - recent advances
Genetic origins of human cancer - recent advances
Anshulekha Patel
 
MOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptx
MOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptxMOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptx
MOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptx
Manjula N
 
Liver cytology
Liver cytologyLiver cytology
Liver cytology
Sansar Babu Tiwari
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
Dr Niharika Singh
 
Pancreas cytology
Pancreas cytologyPancreas cytology
Pancreas cytology
Sansar Babu Tiwari
 
Tensins 123
Tensins 123Tensins 123
Tensins 123
Spoorthy Gurajala
 
Squash smear cytology - By Anamika dev
Squash smear cytology - By Anamika devSquash smear cytology - By Anamika dev
Squash smear cytology - By Anamika dev
Anamika Dev
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemia
Dr. Liza Bulsara
 
Squash cytology of cns paediatric tumours
Squash cytology of cns paediatric tumoursSquash cytology of cns paediatric tumours
Squash cytology of cns paediatric tumoursSumanth Deva
 
CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??! CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??!
Ashish Jawarkar
 
Molecular testing techniques in cytology specimens
Molecular testing techniques in cytology specimensMolecular testing techniques in cytology specimens
Molecular testing techniques in cytology specimens
Sudipta Naskar
 
Immunohistochemistry of Prostatic lesions
Immunohistochemistry of Prostatic lesionsImmunohistochemistry of Prostatic lesions
Immunohistochemistry of Prostatic lesions
Ashish Jawarkar
 
Molecular genetics in soft tissue
Molecular genetics in soft tissueMolecular genetics in soft tissue
Molecular genetics in soft tissueimrana tanvir
 
Ihc oncology.ppt1
Ihc oncology.ppt1Ihc oncology.ppt1
Ihc oncology.ppt1
Dr ABDUL WAHEED DAR
 

What's hot (20)

Immunohistochemistry of Thyroid Gland tumor
Immunohistochemistry of Thyroid Gland tumorImmunohistochemistry of Thyroid Gland tumor
Immunohistochemistry of Thyroid Gland tumor
 
The Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary CytologyThe Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary Cytology
 
Giant cell lesions of bone
Giant cell lesions of boneGiant cell lesions of bone
Giant cell lesions of bone
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
 
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminarImmunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminar
 
Dr shashi bansal approch to bone marrow examination
Dr shashi bansal  approch to bone marrow examinationDr shashi bansal  approch to bone marrow examination
Dr shashi bansal approch to bone marrow examination
 
Genetic origins of human cancer - recent advances
Genetic origins of human cancer  - recent advancesGenetic origins of human cancer  - recent advances
Genetic origins of human cancer - recent advances
 
MOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptx
MOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptxMOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptx
MOLECULAR PROFILING OF OSTEOARTICULAR NEOPLASM.pptx
 
Liver cytology
Liver cytologyLiver cytology
Liver cytology
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
 
Pancreas cytology
Pancreas cytologyPancreas cytology
Pancreas cytology
 
Tensins 123
Tensins 123Tensins 123
Tensins 123
 
Squash smear cytology - By Anamika dev
Squash smear cytology - By Anamika devSquash smear cytology - By Anamika dev
Squash smear cytology - By Anamika dev
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemia
 
Squash cytology of cns paediatric tumours
Squash cytology of cns paediatric tumoursSquash cytology of cns paediatric tumours
Squash cytology of cns paediatric tumours
 
CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??! CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??!
 
Molecular testing techniques in cytology specimens
Molecular testing techniques in cytology specimensMolecular testing techniques in cytology specimens
Molecular testing techniques in cytology specimens
 
Immunohistochemistry of Prostatic lesions
Immunohistochemistry of Prostatic lesionsImmunohistochemistry of Prostatic lesions
Immunohistochemistry of Prostatic lesions
 
Molecular genetics in soft tissue
Molecular genetics in soft tissueMolecular genetics in soft tissue
Molecular genetics in soft tissue
 
Ihc oncology.ppt1
Ihc oncology.ppt1Ihc oncology.ppt1
Ihc oncology.ppt1
 

Similar to Error Trapping and Error Avoidance in Histopathology

Biases in RCT.pptx
Biases in RCT.pptxBiases in RCT.pptx
Biases in RCT.pptx
RanitBag1
 
PURPOSE OF A DIAGNOSTIC LABORATORY
PURPOSE OF A DIAGNOSTIC LABORATORYPURPOSE OF A DIAGNOSTIC LABORATORY
PURPOSE OF A DIAGNOSTIC LABORATORY
Society for Microbiology and Infection care
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...Effective Health Care Program
 
causes of laboratory errors
causes of laboratory errorscauses of laboratory errors
causes of laboratory errors
Shahad Bakhdar
 
Assessing Applicability
Assessing ApplicabilityAssessing Applicability
Assessing Applicability
Effective Health Care Program
 
Considering adverse effects in prioritising reviews
Considering adverse effects in prioritising reviewsConsidering adverse effects in prioritising reviews
Considering adverse effects in prioritising reviewsCochrane.Collaboration
 
MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...
MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...
MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...European School of Oncology
 
Assessment of Bias
Assessment of BiasAssessment of Bias
Assessment of Bias
Francisco J Grajales III
 
Malimu sources of errors
Malimu sources of errorsMalimu sources of errors
Malimu sources of errors
Miharbi Ignasm
 
Bias in clinical research
Bias in clinical research Bias in clinical research
Bias in clinical research
sathyanarayanan varadarajan
 
Evidence and guidelines COMEP
Evidence and guidelines COMEPEvidence and guidelines COMEP
Evidence and guidelines COMEP
NES
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
sanjay negi
 
Dr. negi quality assurance
Dr. negi quality assuranceDr. negi quality assurance
Dr. negi quality assurance
sanjay negi
 
C H A P T E R 1 Clinical rea
C H A P T E R  1  Clinical reaC H A P T E R  1  Clinical rea
C H A P T E R 1 Clinical rea
TawnaDelatorrejs
 
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdfPathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Priyankapandey782070
 
bias and error-final 1.pptx
bias and error-final 1.pptxbias and error-final 1.pptx
bias and error-final 1.pptx
laxmibhattalamichhan
 
CLINICAL AUDIT
CLINICAL AUDITCLINICAL AUDIT
CLINICAL AUDIT
S A Tabish
 

Similar to Error Trapping and Error Avoidance in Histopathology (20)

Biases in RCT.pptx
Biases in RCT.pptxBiases in RCT.pptx
Biases in RCT.pptx
 
PURPOSE OF A DIAGNOSTIC LABORATORY
PURPOSE OF A DIAGNOSTIC LABORATORYPURPOSE OF A DIAGNOSTIC LABORATORY
PURPOSE OF A DIAGNOSTIC LABORATORY
 
Study Eligibility Criteria
Study Eligibility CriteriaStudy Eligibility Criteria
Study Eligibility Criteria
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...
 
causes of laboratory errors
causes of laboratory errorscauses of laboratory errors
causes of laboratory errors
 
Assessing Applicability
Assessing ApplicabilityAssessing Applicability
Assessing Applicability
 
Considering adverse effects in prioritising reviews
Considering adverse effects in prioritising reviewsConsidering adverse effects in prioritising reviews
Considering adverse effects in prioritising reviews
 
MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...
MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...
MON 2011 - Slide 2 - L. Sharp - Keynote lecture - Developing the evidence bas...
 
Assessment of Bias
Assessment of BiasAssessment of Bias
Assessment of Bias
 
DUR Lecture - II (1).pptx
DUR Lecture - II (1).pptxDUR Lecture - II (1).pptx
DUR Lecture - II (1).pptx
 
Malimu sources of errors
Malimu sources of errorsMalimu sources of errors
Malimu sources of errors
 
Dhiwahar ppt
Dhiwahar pptDhiwahar ppt
Dhiwahar ppt
 
Bias in clinical research
Bias in clinical research Bias in clinical research
Bias in clinical research
 
Evidence and guidelines COMEP
Evidence and guidelines COMEPEvidence and guidelines COMEP
Evidence and guidelines COMEP
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
 
Dr. negi quality assurance
Dr. negi quality assuranceDr. negi quality assurance
Dr. negi quality assurance
 
C H A P T E R 1 Clinical rea
C H A P T E R  1  Clinical reaC H A P T E R  1  Clinical rea
C H A P T E R 1 Clinical rea
 
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdfPathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
 
bias and error-final 1.pptx
bias and error-final 1.pptxbias and error-final 1.pptx
bias and error-final 1.pptx
 
CLINICAL AUDIT
CLINICAL AUDITCLINICAL AUDIT
CLINICAL AUDIT
 

More from drshameera

Clear cell variant of renal cell acrcinoma
Clear cell variant of renal cell acrcinomaClear cell variant of renal cell acrcinoma
Clear cell variant of renal cell acrcinoma
drshameera
 
World Blood donor day
World Blood donor dayWorld Blood donor day
World Blood donor day
drshameera
 
Sebaceous carcinoma 9.6.17
Sebaceous carcinoma   9.6.17Sebaceous carcinoma   9.6.17
Sebaceous carcinoma 9.6.17
drshameera
 
Carcinoma larynx
Carcinoma larynx  Carcinoma larynx
Carcinoma larynx
drshameera
 
Correlation between cytology and histopathological examination of endometrium...
Correlation between cytology and histopathological examination of endometrium...Correlation between cytology and histopathological examination of endometrium...
Correlation between cytology and histopathological examination of endometrium...
drshameera
 
Total leukocyte count - TLC
Total leukocyte count - TLCTotal leukocyte count - TLC
Total leukocyte count - TLC
drshameera
 
Lower GIT
Lower GITLower GIT
Lower GIT
drshameera
 
Upper git and salivary gland
Upper git and salivary glandUpper git and salivary gland
Upper git and salivary gland
drshameera
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
drshameera
 
Breast Filariasis
Breast FilariasisBreast Filariasis
Breast Filariasis
drshameera
 
Basal Cell Carcinoma
Basal Cell CarcinomaBasal Cell Carcinoma
Basal Cell Carcinoma
drshameera
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
drshameera
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
drshameera
 
Dissertation protocol
Dissertation protocolDissertation protocol
Dissertation protocol
drshameera
 

More from drshameera (14)

Clear cell variant of renal cell acrcinoma
Clear cell variant of renal cell acrcinomaClear cell variant of renal cell acrcinoma
Clear cell variant of renal cell acrcinoma
 
World Blood donor day
World Blood donor dayWorld Blood donor day
World Blood donor day
 
Sebaceous carcinoma 9.6.17
Sebaceous carcinoma   9.6.17Sebaceous carcinoma   9.6.17
Sebaceous carcinoma 9.6.17
 
Carcinoma larynx
Carcinoma larynx  Carcinoma larynx
Carcinoma larynx
 
Correlation between cytology and histopathological examination of endometrium...
Correlation between cytology and histopathological examination of endometrium...Correlation between cytology and histopathological examination of endometrium...
Correlation between cytology and histopathological examination of endometrium...
 
Total leukocyte count - TLC
Total leukocyte count - TLCTotal leukocyte count - TLC
Total leukocyte count - TLC
 
Lower GIT
Lower GITLower GIT
Lower GIT
 
Upper git and salivary gland
Upper git and salivary glandUpper git and salivary gland
Upper git and salivary gland
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Breast Filariasis
Breast FilariasisBreast Filariasis
Breast Filariasis
 
Basal Cell Carcinoma
Basal Cell CarcinomaBasal Cell Carcinoma
Basal Cell Carcinoma
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Dissertation protocol
Dissertation protocolDissertation protocol
Dissertation protocol
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 

Error Trapping and Error Avoidance in Histopathology

  • 1. ERROR TRAPPING AND ERROR AVOIDANCE IN HISTOPATHOLOGY
  • 2. Error rates in diagnostic histopathology  A typical histopathologist becomes aware of having made a serious diagnostic error about once a year  Overall diagnostic error – 3 to 4%  Clinically significant error – 1 to 2%  “Zero error rate” – cannot be achieved even with use of automated re-screening devices
  • 3. Classification of diagnostic errors Category 1 A diagnostic error which would have a definite influence on clinical management and possible outcome Category 2 A diagnostic misinterpretation or oversight which has the potential to affect clinical management or outcome Category 3 A minor discrepancy of disease categorization likely to be of little clinical significance
  • 4. What sort of errors are made?  Oversight errors  Misinterpretation errors  Errors are rarely due to incompetence, lack of knowledge or inability to do the work  Other factors – heavy workload  Areas where pathologists tend to make more mistakes – lymphoma, melanoma, prostate needle biopsies.  Physical impairment of visual function, colour blindness  There is no evidence that pathologists with inability to distinguish subtle colour hues perform less well than others
  • 5. Individual professional performance Pathologists should be  Up-to-date with their specialist knowledge  Right skills and attitude to manage services  Communicate effectively  Audit their performance  Re – validation or re-licensing process
  • 6. Good pathology practice Pathologists should  Assure the quality of clinical advice given and associated record keeping  Ensure the quality and timeliness of pathology reports and clinical advice  Undertake routine review (audit) of a sample of clinical cases / reports in selected areas  Show that individual diagnostic patterns compare favourably with their peers  Offer appropriate treatment, management or diagnostic decision making  Describe the distribution of their workload and case-mix
  • 7. Professional behaviour and working relationships All pathologists must  Be available and willing to communicate and discuss clinical and professional issues with colleagues  Know their own diagnostic limitations as demonstrated by their referral patterns  Participate in clinicopathological discussions or multidisciplinary team meetings  Work well in a team  Ensure that there are no tensions relating to private practice, coroner’s work or outside commitments
  • 8. Identifying poor performance  Identifying underperforming pathologists  Errors should not be judged in isolation but in the context of pathologist’s overall performance  The performance of doctors should be assessed using Cambridge model approach, which applies a range of methods and indicators that take into account both individual competence and day-to-day work context
  • 9. Factors leading to increased risk of errors and poor performance in histopathology  Conditions of work, staffing and workload  Locum working in unfamiliar surroundings  Potential constraints on performance in the laboratory  Low volume work or case-mix and where the pathologist may be working outside his or her expertise  Isolated or single-handed practice
  • 10. Clinical audit  Reliable and systematized audit practice  Audit is used to monitor diagnostic and service standards and identify and prevent errors  Audit and peer review are useful in reducing inaccuracies in reports
  • 11. Specialist reporting  Specialist reporting reduces the number of errors made
  • 12. Quality improvement systems Type of review Process Intradepartmental consultation Review of selected cases by colleagues Intra- operative consultation (frozen section) Review of frozen section diagnosis in the light of final paraffin wax section diagnosis Random case review Re-reporting of a random sample from all cases submitted Clinical indicator audit Cases selected on a clinical basis checked over a given period to ensure consistency in diagnosis and reporting Multidisciplinary Team Meeting Comparison of presented diagnosis against reported diagnoses Inter- institutional review Comparison of local diagnoses with outside review diagnoses Reporting patterns Comparison of pattern of reporting among group of pathologists
  • 13. Quality improvement systems Type of review Process Workload profile Audit of busy and quiet periods Turnaround times Audit of time taken to produce reports Specimen adequacy Monitoring identification and processing of specimens Lost specimens Monitoring number of lost specimens Histology quality control Assessment of times of delivery of slides and quality of staining
  • 14. Other methods to detect errors  Consistency in reporting  Patterns of error -analysis of diagnostic pattern( use of inappropriate or inconsistent terminology)  Case referral  Multidisciplinary team meetings  Use of guidelines and datasets  External quality assurance  Risk management  Adverse incident reporting  Hindsight bias
  • 15. Conclusions  The detection of errors and error avoidance depends upon individuals practising to the highest standards by ensuring they are up-to-date  Pathologists should be willing to monitor their own performance, know their limitations and communicate with peers  Pathologists should engage in the process of developing standardized approaches to macroscopic description, specimen sampling, special stains and histological reporting  The laboratories in which pathologists work should have systematized method of audit, quality improvement and IT systems to analyze the data and to identify poor performance at an early stage
  • 16. Thank you… To make no mistakes is not in the power of man; but from their errors and mistakes the wise and good learn wisdom for the future.

Editor's Notes

  1. quantifying the degree of interpretation- grading of tumor, depth of invasion